Published in J Biol Chem on May 30, 2003
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med (2007) 2.23
Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life (2012) 1.70
Redox regulation of mitochondrial function. Antioxid Redox Signal (2012) 1.34
Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med (2014) 1.27
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J (2009) 1.25
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. Nat Rev Drug Discov (2015) 1.14
Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J Biol Chem (2009) 1.08
Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response. J Mol Cell Cardiol (2010) 1.08
Endothelial PFKFB3 plays a critical role in angiogenesis. Arterioscler Thromb Vasc Biol (2014) 0.99
Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J (2009) 0.98
Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation. BMC Cardiovasc Disord (2013) 0.95
Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction. Antioxid Redox Signal (2010) 0.93
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab (2014) 0.92
Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose. PLoS One (2012) 0.91
Systems analysis of oxidant stress in the vasculature. IUBMB Life (2013) 0.84
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria. Malar J (2016) 0.82
Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress. Mol Cell Biol (2013) 0.79
Characterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells. Free Radic Biol Med (2011) 0.79
Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease. J Inherit Metab Dis (2015) 0.78
Antioxidant enzyme deficiencies and vascular disease. Expert Rev Endocrinol Metab (2010) 0.78
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy. Int J Med Sci (2013) 0.78
Redox Pioneer: Professor Joseph Loscalzo. Antioxid Redox Signal (2010) 0.77
Role of genetic changes in the progression of cardiovascular diseases. Int J Biomed Sci (2011) 0.77
Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide. J Neuroinflammation (2017) 0.75
Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro. Mol Cell Biochem (2010) 0.75
Central Role of Metabolism in Endothelial Cell Function and Vascular Disease. Physiology (Bethesda) (2017) 0.75
Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease. Glob Cardiol Sci Pract (2016) 0.75
Endothelial cell metabolism in health and disease: impact of hypoxia. EMBO J (2017) 0.75
Is glucose-6-phosphate dehydrogenase deficiency a risk factor for hyperbaric oxygen exposure? Eur J Appl Physiol (2011) 0.75
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One (2010) 7.48
Pulmonary arterial hypertension. N Engl J Med (2004) 6.69
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Evaluation of a redesign initiative in an internal-medicine residency. N Engl J Med (2010) 4.85
Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res (2006) 3.57
Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell (2007) 3.54
MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab (2009) 3.30
Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke (2006) 2.54
A cost comparison of more and less nutritious food choices in US supermarkets. Public Health Nutr (2011) 2.25
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med (2007) 2.23
MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle (2010) 2.18
Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16
Homocysteine trials--clear outcomes for complex reasons. N Engl J Med (2006) 2.12
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12
Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med (2015) 2.12
Lipid levels after acute coronary syndromes. J Am Coll Cardiol (2008) 2.05
Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res (2005) 2.04
Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res (2003) 1.99
Internal medicine residency redesign: proposal of the Internal Medicine Working Group. Am J Med (2011) 1.89
Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol (2007) 1.85
Cyclooxygenase inhibition and cardiovascular risk. Circulation (2005) 1.81
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation (2012) 1.75
Mcl-1 is essential for the survival of plasma cells. Nat Immunol (2013) 1.73
Use of colorimetric test strips for monitoring the effect of hemodialysis on salivary nitrite and uric acid in patients with end-stage renal disease: a proof of principle. Clin Chem (2008) 1.72
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res (2002) 1.69
Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Circ Res (2004) 1.69
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation (2005) 1.69
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity (2013) 1.67
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation (2004) 1.65
Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation (2002) 1.65
Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke (2007) 1.63
Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. J Rheumatol (2007) 1.62
Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2011) 1.57
Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg (2007) 1.54
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol (2003) 1.53
Genetically encoded fluorescent sensors for intracellular NADH detection. Cell Metab (2011) 1.47
Clinical problem-solving. Whistling in the dark. N Engl J Med (2012) 1.42
S-nitrosoprotein formation and localization in endothelial cells. Proc Natl Acad Sci U S A (2004) 1.40
Clinical problem-solving. Breathtaking journey. N Engl J Med (2012) 1.38
Clinical problem-solving. A fragile balance. N Engl J Med (2009) 1.38
Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice. Am J Physiol Heart Circ Physiol (2008) 1.36
Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol (2005) 1.36
Sleep and cardiovascular disease: an overview. Prog Cardiovasc Dis (2008) 1.36
Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation (2002) 1.35
The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood (2010) 1.35
Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol (2005) 1.34
Redox regulation of mitochondrial function. Antioxid Redox Signal (2012) 1.34
Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol (2003) 1.33
Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem (2005) 1.31
Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med (2013) 1.30
Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol (2002) 1.29
Serial noninvasive assessment of progressive pulmonary hypertension in a rat model. Am J Physiol Heart Circ Physiol (2002) 1.29
Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood (2005) 1.28
Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem (2009) 1.27
Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation (2012) 1.27
Primer on medical genomics. Part XIV: Introduction to systems biology--a new approach to understanding disease and treatment. Mayo Clin Proc (2004) 1.27
Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology (2008) 1.25
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J (2009) 1.25
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation (2002) 1.24
The treatment of hyperhomocysteinemia. Annu Rev Med (2009) 1.23
Regulation of the protein disulfide proteome by mitochondria in mammalian cells. Proc Natl Acad Sci U S A (2007) 1.21
Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol (2002) 1.20
Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation (2011) 1.20
The validation of a food label literacy questionnaire for elementary school children. J Nutr Educ Behav (2012) 1.20
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature. Am J Cardiol (2008) 1.17
The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol (2004) 1.16
Chlamydia screening--Australia should strive to achieve what others have not. Med J Aust (2008) 1.15
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med (2002) 1.14
Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation (2011) 1.13
Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J Biol Chem (2003) 1.13
The emerging paradigm of network medicine in the study of human disease. Circ Res (2012) 1.12
Rural children with asthma: impact of a parent and child asthma education program. J Asthma (2005) 1.12
Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol (2003) 1.12
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. J Card Fail (2002) 1.11
Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol (2011) 1.11
Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci (2008) 1.10
Platelets and cardiovascular disease. Eur J Cardiovasc Nurs (2002) 1.10
Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction. Clin Chem Lab Med (2003) 1.10
Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun (2011) 1.09